Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead.
Gilead shows its belief in its partner’s cancer treatment with a $7.8 billion buyout
Related Posts
Popular News
Latest News
Trump administration Harvard lawsuit: impact on applicants
With the Trump administration reigniting its battle with Harvard University, future applicants may be wondering where they stand.In the latest blow,...
The 3 Rs of a great CV
A great CV is more than a just dry account of your responsibilities and career history. To truly shine, you...
Trump renews attack on US Supreme Court, vows other tariffs, licenses
Trump renews attack on US Supreme Court, vows other tariffs, licenses
5C Investment Partners announces tie-up with Qatar Investment Authority to expand platform
5C Investment Partners has announced a strategic partnership with the Qatar Investment Authority to help expand its direct lending platform...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.